Show simple item record

2009-06-05Zeitschriftenartikel DOI: 10.1515/CCLM.2009.243
Leptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
dc.contributor.authorNagy, Balint
dc.contributor.authorVarkonyi, Tibor
dc.contributor.authorMolvarec, Attila
dc.contributor.authorLazar, Levente
dc.contributor.authorHupuczi, Petronella
dc.contributor.authorThan, Nandor Gabor
dc.contributor.authorRigo, Janos
dc.date.accessioned2017-06-17T05:27:10Z
dc.date.available2017-06-17T05:27:10Z
dc.date.created2010-07-01
dc.date.issued2009-06-05
dc.identifier.issn1437-4331
dc.identifier.urihttp://edoc.hu-berlin.de/18452/11410
dc.description.abstractBackground: Leptin plays an important role in energy homeostasis. There is polymorphism on the leptin (LEP) gene. Our aim was to compare the tetranucleotide repeat (TTTC)n polymorphism in the 3′-flanking region in the LEP gene on DNA samples from patients with pre-eclampsia (PE), hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome and healthy pregnant controls. Methods: Blood samples were collected from healthy pregnant women (n=88), patients with PE (n=79) and HELLP (n=77) syndrome. Fluorescent PCR and DNA fragment analysis was performed from the isolated DNA for the detection of (TTTC) repeats. The electrophoretograms were evaluated and patients were assigned to two groups; class I low (<190 bp) or class II high (≥190 bp) PCR fragments. Results: We observed similar distributions of the class I and class II (TTTC) alleles in the groups studied (class I allele: healthy pregnant 58.5%; severe pre-eclamptic 58.3%; HELLP syndrome 52.6%). We detected a higher frequency of the II/II genotype in HELLP syndrome patients (32.4%) compared to healthy controls (22.7%). However, the difference was not statistically significant. Conclusions: In an ethnically homogenous population, the LEP gene (TTTC) microsatellite polymorphism in the 3′-flanking region does not show a significant difference in the allele and genotype distribution in healthy pregnant, pre-eclamptic and HELLP syndrome patients. Furthermore, we recommend a new classification of the class I and class II alleles based on the distribution of the (TTTC) microsatellites. Clin Chem Lab Med 2009;47:1033–7.eng
dc.language.isound
dc.publisherKooperation de Gruyter
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.titleLeptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:11-100132207
dc.identifier.doi10.1515/CCLM.2009.243
dc.identifier.doihttp://dx.doi.org/10.18452/10758
local.edoc.container-titleClinical Chemistry and Laboratory Medicine
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-publisher-namede Gruyter
local.edoc.container-volume47
local.edoc.container-issue9
local.edoc.container-year2009
local.edoc.container-firstpage1033
local.edoc.container-lastpage1037
dc.description.versionPeer Reviewed

Show simple item record